CETP Inhibition: What We've Learned and What's Next: Quickfire Countdown

Explore modern strategies for Lennox-Gastaut syndrome. Join experts to navigate polypharmacy, manage treatment side effects, and improve care. Credit available for this activity expires: 6/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/updates-anti-seizure-medications-management-lennox-gastaut-2026a1000m36?ecd=bdc_podcast_libsyn_mscpedu

Master the latest evidence-based meds and dual therapies to help your patients quit for good. Credit available for this activity expires: 6/25/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/pharmacological-and-combination-interventions-nicotine-2026a1000ldi?ecd=bdc_podcast_libsyn_mscpedu

Did you know next-generation contrast agents can produce clearer images while substantially reducing gadolinium exposure? Learn more. Credit available for this activity expires: 6/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/next-generation-gadolinium-based-contrast-agents-advancing-2026a1000l3e?ecd=bdc_podcast_libsyn_mscpedu

Discover how B-cell modulation is reshaping immunoglobulin A nephropathy (IgAN) care, halting disease progression, and preserving long-term kidney function. Credit available for this activity expires: 06/24/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/new-frontiers-iga-nephropathy-understanding-role-b-cell-2026a1000l9s?ecd=bdc_podcast_libsyn_mscpedu

Are you effectively linking cognitive tools with biomarkers for accurate Alzheimer's disease (AD) diagnosis? Credit available for this activity expires: 06/25/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/case-based-discussion-linking-cognitive-testing-biomarker-2026a1000law?ecd=bdc_podcast_libsyn_mscpedu

Is your patient stable or truly optimized? Rethink your approach with next-generation anti-vascular endothelial growth factor (VEGF) therapies. Credit available for this activity expires: 6/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/retina-futures-forum-focus-wet-amd-2026a1000jv4?ecd=bdc_podcast_libsyn_mscpedu

Still using androgen deprivation therapy (ADT) alone for patients with metastatic hormone-sensitive prostate cancer (mHSPC)? Learn the latest on optimizing outcomes with combination therapies. Credit available for this activity expires: 6/25/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/new-era-mhspc-treatment-evaluating-emerging-doublet-and-2026a1000kt7?ecd=bdc_podcast_libsyn_mscpedu

New strategies for tackling nicotine in at-risk groups. Credit available for this activity expires: 06/25/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/health-risks-nicotine-use-focus-risk-populations-2026a1000eyj?ecd=bdc_podcast_libsyn_mscpedu

Optimize depression care: Master shared decision-making and integrate novel MOAs, fast-acting therapies, and validated assessment tools. Credit available for this activity expires: 6/25/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/best-practices-clinician-patient-shared-decision-making-2026a1000kiq?ecd=bdc_podcast_libsyn_mscpedu

Why did early cholesteryl ester transfer protein (CETP) inhibitors fail despite raising high-density lipoprotein cholesterol (HDL-C), and how does contemporary evidence change the therapeutic outlook? Credit available for this activity expires: 6/24/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/cetp-inhibition-what-weve-learned-and-whats-next-quickfire-2026a1000kip?ecd=bdc_podcast_libsyn_mscpedu